Showing results (161-170 of 204) with videos related to
Sort By:
Pageof 21
Journal of Leukocyte Biology|December 30, 1999
P40phox associates with the neutrophil Triton X-100-insoluble cytoskeletal fraction and PMA-activated membrane skeleton: a comparative study with P67phox and P47phoxJ El Benna, P M Dang, V Andrieu, et al.Scientific Reports|June 11, 2021
Hydrothermally synthesized nanostructured LiMnxFe1-xPO4 (x = 0-0.3) cathode materials with enhanced properties for lithium-ion batteriesDung V Trinh, Mai T T Nguyen, Hue T M Dang, et al.Research Square|March 30, 2023
Organoid modeling reveals the tumorigenic potential of the alveolar progenitor cell stateJingyun Li, Susanna M Dang, Paul Schurmann, et al.Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi = Zhonghua Laodong Weisheng Zhiyebing Zazhi = Chinese Journal of Industrial Hygiene and Occupational Diseases|September 30, 2016
[An investigation of mental health in migrant workers in an enterprise]Z H Sun, Z Z Wu, W M Dang, et al.AJNR. American Journal of Neuroradiology|September 27, 2014
MRI texture analysis predicts p53 status in head and neck squamous cell carcinomaM Dang, J T Lysack, T Wu, et al.Global Health, Science and Practice|October 3, 2020
Mask Reuse in the COVID-19 Pandemic: Creating an Inexpensive and Scalable Ultraviolet System for Filtering Facepiece Respirator DecontaminationRachel M Gilbert, Michael J Donzanti, Daniel J Minahan, et al.Physical Review Letters|September 2, 2022
Unveiling the Enhancement of Spontaneous Emission at Exceptional PointsL Ferrier, P Bouteyre, A Pick, et al.Physical Chemistry Chemical Physics : PCCP|December 22, 2009
Electron attachment and electron ionization of acetic acid clusters embedded in helium nanodropletsF Ferreira da Silva, S Jaksch, G Martins, et al.Pediatric Blood & Cancer|September 8, 2021
Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology GroupAnderson B Collier, Mark D Krailo, Ha M Dang, et al.Clinical & Experimental Ophthalmology|November 20, 2025
Twelve-Month Outcomes of Brolucizumab in Routine Clinical Practice: Fight Retinal Blindness! RegistryTrung M Dang, Alessandro Invernizzi, Vuong Nguyen, et al.Pageof 21